Novavax Aims to Deploy Covid-19 Vaccine by December: R&D Head

Aug.05 — Dr. Gregory Glenn, Novavax president of research and development, discusses the progress on the company’s experimental vaccine for Covid-19 with Bloomberg’s Alix Steel on “Bloomberg Markets.”